Froedtert surgeons used an FDA‑approved "glowing" drug to find a tiny lung tumor and spare healthy lung tissue.

Dr. Douglas Wood, Henry N. Harkins Endowed Professor, chair of the UW Medicine department of surgery, and recipient of the UW 2025 University Faculty Lecture Award, spoke on his lung cancer screening and patient advocacy over the past 15 years in the 2026 University Faculty Lecture on Feb. 5.

Surgery is a common treatment for non-small cell lung cancer (NSCLC), particularly when the disease is detected early and the tumor is small and is only in one part of the lung. For small cell lung cancer (SCLC), physicians rarely use surgery because by ...

Doctors at Main Line Health now have a new kind of robotic surgery that makes recovery quicker and easier for lung cancer patients. Traditional lung cancer surgery usually involves some pain and a longer recovery. That's now changing thanks to a specially ...

A new drug is helping surgeons see cancer that once went undetected, lighting up tumors in real time during surgery.Dr. Mallory Hunt, an assistant professor of cardiothoracic surgery

Laura Hamann's story is part of a growing trend that's changing everything you thought you knew about lung cancer.

Adults living in rural communities often travel long distances when seeking treatment for cancer, but distant travel may not always be necessary to receive high-quality surgical care, according to a new analysis published in the Journal of the American College of Surgeons.

Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with standard chemotherapy before surgery had improved long ...

From a potential new flu vaccine to a groundbreaking surgical first and critical health reminders, here's today's essential health news.